Home > Boards > US Listed > Biotechs > Cytokinetics, Inc. (CYTK)

Hey Sugarshaker,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
H2R Member Profile
 
Followed By 25
Posts 1,833
Boards Moderated 0
Alias Born 07/17/14
160x600 placeholder
Cytokinetics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 3/2/2021 4:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/1/2021 5:06:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/1/2021 5:05:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/1/2021 5:02:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/1/2021 6:06:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/26/2021 6:25:43 PM
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 2/26/2021 4:32:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2021 7:30:58 AM
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day GlobeNewswire Inc. - 2/26/2021 7:30:00 AM
Cytokinetics EPS misses by $0.13, misses on revenue Seeking Alpha - 2/25/2021 4:19:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 4:01:19 PM
Cytokinetics Reports Fourth Quarter 2020 Financial Results GlobeNewswire Inc. - 2/25/2021 4:00:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/19/2021 5:03:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/19/2021 4:20:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/18/2021 7:30:59 AM
Cytokinetics Names Muna Bhanji to Board of Directors GlobeNewswire Inc. - 2/18/2021 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 3:17:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/12/2021 6:39:21 PM
Cytokinetics to Announce Fourth Quarter Results on February 25, 2021 GlobeNewswire Inc. - 2/11/2021 4:00:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 10:50:19 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/8/2021 10:08:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/2/2021 7:30:48 AM
Cytokinetics Announces Recipients of Third Annual Communications Fellowship Grants GlobeNewswire Inc. - 2/2/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/1/2021 4:00:56 PM
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 2/1/2021 4:00:00 PM
H2R   Monday, 11/20/17 03:44:41 PM
Re: Sugarshaker post# 1468
Post # of 1503 
Hey Sugarshaker,

I just saw your post, sorry for the delay.

I would say 60-70% chances of positive news. This is just my opinion, nothing more.

Why positive? Because of slide 16 of http://ir.cytokinetics.com/static-files/6522ceaf-feee-4a48-b8dc-cb767de92a8f.

If you look at the p-values, they are pretty darn good for SVC.

And Ph III's primary endpoint is SVC.

Why only 60-70% chances?

Mostly because ALS is such a tough disease to beat. Many companies fell short in many, many clinical trials.

Anyways, I keep on hoping.

Also, if the initial indication is positive, CYTK may get some milestone payment. Not sure exactly when, but it's $100M. Not too shabby.

Best of luck!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences